Real-world study of antiresorptive-related osteonecrosis of jaw based on the US food and drug administration adverse event reporting system database

Objective: This study aims to explore the risk signals of osteonecrosis of the jaw induced by antiresorptive drugs and provide references for the clinical safety application. Method: According to the FDA’s Adverse Event Reporting System (FAERS), from January 2004 to September 2021, we chose “Osteone...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Jing, Wang, Hui, Liu, Zhen, Xu, Zhen-Liang, Wang, Mei-Xia, Chen, Qi-Miao, Wu, Ming-Li, Ren, Xiao-Lei, Liang, Qiu-Hua, Liu, Fu-Peng, Ban, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627332/
https://www.ncbi.nlm.nih.gov/pubmed/36339548
http://dx.doi.org/10.3389/fphar.2022.1017391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627332/
https://www.ncbi.nlm.nih.gov/pubmed/36339548
http://dx.doi.org/10.3389/fphar.2022.1017391

Ejemplares similares